Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled,...

por Wietecha, Linda A., Clemow, David B., Buchanan, Andrew S., Young, Joel L., Sarkis, Elias H., Findling, Robert L.
Publicado 2016

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

por Findling, Robert L., Robb, Adelaide S., DelBello, Melissa P., Huss, Michael, McNamara, Nora K., Sarkis, Elias H., Scheffer, Russell E., Poulsen, Lis H., Chen, Grace, Lemming, Ole M., Auby, Philippe
Publicado 2018

Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

por Satram, Sacha, Ghafoori, Parima, Reyes, Carolina M., Keeley, Tom J. H., Birch, Helen J., Brintziki, Dimitra, Aldinger, Melissa, Alexander, Elizabeth, Lopuski, Amanda, Sarkis, Elias H., Gupta, Anil, Shapiro, Adrienne E., Powers, John H.
Publicado 2023

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

por Agostini, Maria L, Schnell, Gretja, di Iulio, Julia, Kohli, Anita, Shapiro, Adrienne E, Sarkis, Elias H, Inman, Dave, Peppercorn, Amanda, Skingsley, Andrew, Gaffney, Leah A, Aldinger, Melissa, Hebner, Christy M, Cathcart, Andrea L
Publicado 2022

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

por Gupta, Anil K, Rojas, Yaneicy Gonzalez, Juarez, Erick, Casal, Manuel Crespo, Moya, Jaynier, Falci, Diego Rodrigues, Sarkis, Elias H, Solis, Joel, Zheng, Hanzhe, Scott, Nicola, Cathcart, Andrea L, Hebner, Christy, Sager, Jennifer, Mogalian, Erik, Austin, Daren, Peppercorn, Amanda, Alexander, Elizabeth L, Yeh, Wendy W, Free, Almena, Brinson, Cynthia, Aldinger, Melissa, Shapiro, Adrienne
Publicado 2021